Monica Bertagnolli began work as 16th director of the National Cancer Institute
On Oct. 3, 2022, Monica M. Bertagnolli, M.D., started as the 16th director of the National Cancer Institute….
-
-
EMA accepted Moderna’s conditional Marketing Authorization filing for omicron BA.4/BA.5 targeting bivalent COVID-19 vaccine
On Sept. 29, 2022, Moderna announced that the European Medicines Agency (EMA) had accepted a variation for the…
-
Biotechnology | Disease | WHO
WHO launched new initiative to stop the spread of invasive malaria vector in Africa
On Sept. 29, 2022, the World Health Organization announced that it had identified the spread of Anopheles stephensi…
-
USDA confirmed two cases of highly pathogenic avian influenza in neighboring non-commercial flocks in Tillamook County
On Sept. 28, 2022, the U.S Department of Agriculture’s Animal Plant Health Inspection Service (USDA APHIS) confirmed two…
-
Pfizer and BioNTech completed submission to EMA for Omicron BA.4/BA.5-adapted bivalent vaccine Booster in children 5 through 11 years of age
On Sept. 28, 2022, Pfizer and BioNTech announced they had completed a submission to the European Medicines Agency…
-
Study confirmed link between COVID-19 vaccination and temporary increase in menstrual cycle length
On Sept. 27, 2022, the National Institutes of Health (NIH) announced that a large international study had confirmed…
-
Novavax made one million doses of Nuvaxovid available for use in the United Kingdom
On Sept. 27, 2022, Novavax announced that an initial one million doses of Nuvaxovid (NVX-CoV2373) COVID-19 vaccine were…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
NIH established initiative to systematically investigate and establish function of every human gene
On Sept. 27, 2022, the National Institutes of Health (NIH) announced it had launched a program to better…
-
Scientists used modified silk proteins to create new nonstick surfaces
On Sept. 23, 2022, researchers at Tufts University announced they had developed a method to make silk-based materials…
-
Pfizer to supply global fund up to 6 million PAXLOVID treatment courses for low-and-middle-income countries
On Supt. 22, 2022, Pfizer announced an agreement to supply up to six million treatment courses of its…
-
Salk Institute to lead $126 million effort to map the aging human brain
On Supt. 22, 2022, with a five-year, $126 million grant from the National Institutes of Health (NIH), a…
-
Bill & Melinda Gates Foundation Announces $1.27B in Health and Development Commitments to Advance Progress Toward the Global Goals
On Sept. 21, 2022, during United Nations General Assembly week, the Bill & Melinda Gates Foundation—alongside governments, philanthropies,…
-
Diagnostics | FDA | NIH | Oncology
U.S. recorded steady decline in cancer death rates
On Sept. 21, 2022, the American Association for Cancer Research (AACR) released the 12th edition of its AACR…
-
Uganda declared Ebola virus disease outbreak
On Sept. 20, 2022, health authorities in Uganda declared an outbreak of Ebola after a case of the…
-
Malaria spike linked to amphibian die-off
On Sept. 20, 2022, the University of California, Davis announced that the amphibian decline in Latin America in…
-
Democratic Republic of the Congo Ebola outbreak declared over, Uganda boosted response
On Sept. 17, 2022, the Democratic Republic of the Congo declared the end of an Ebola outbreak that…
-
Novavax Nuvaxovid COVID-19 vaccine became available in Israel for individuals aged 12 and older
On Sept. 16, 2022, Novavax announced that the Israel Ministry of Health has granted an import and use…
-
Novavax Nuvaxovid COVID-19 vaccine received expanded EUA in Taiwan for use in adolescents aged 12 through 17
On Sept. 16, 2022, Novavax announced that the Taiwan Food and Drug Administration had granted expanded emergency use…
-
NIH-funded team developed method to identify future SARS-CoV-2 mutations that could affect rapid antigen test performance
On Sept. 15, 2022, the National Institutes of Health (NIH) announced that a research team funded by the…
-
WHO expanded recommendation for Veklury (Remdesivir) to patients with severe disease in update to COVID-19 guideline
On Sept. 15, 2022, Gilead Sciences announced updates to the World Health Organization’s (WHO) Therapeutics and COVID-19: living…
-
USDA confirmed highly pathogenic Avian influenza in Tennessee
On Sept. 15, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
-
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Medicine | Nanotechnology | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
U.S. Biotechnology & Biomanufacturing Initiative
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
-
NIH launched Bridge2AI program to expand the use of artificial intelligence in biomedical and behavioral research
On Sept. 13, 2022, the National Institutes of Health announced it will invest $130 million over four years,…
-
Novavax and Serum Institute of India announced full product registration in South Africa of Novavax COVID-19 vaccine
On Sept. 13, 2022, Novavax and Serum Institute of India, the world’s largest vaccine manufacturer by volume, announced…
-
White House Executive Order advanced National Biotechnology and Biomanufacturing Initiative
On Sept. 12, 2022, the White House announced an executive order to advance biotechnology and biomanufacturing towards innovative…
-
Biotechnology | Diagnostics | Disease | Vaccine | WHO
Malaria booster vaccine showed durable high efficacy in African children, meeting WHO-specified 75% efficacy goal
On Sept. 8, 2022, researchers from the University of Oxford and their partners reported findings from their Phase…
-
Clinical trial evaluating Mpox vaccine began
On Sept. 8, 2022, a clinical trial evaluating alternative strategies for administering the JYNNEOS mpox vaccine to increase…
-
Fred Hutchinson Cancer Center received $78 million gift to support precision oncology
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
-
Biotechnology | Cosmetic | FDA | Therapeutics
FDA Approved Daxxify, a New Anti-Wrinkle Drug
On Sept. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had approved Revance Therapeutics’ DAXXIFY…
-
FDA authorized Quest Diagnostics’ proprietary Mpox test for emergency use
On Sept. 7, 2022, Quest Diagnostics announced that it had received emergency use authorization (EUA) from the U.S….
